Tyler Muﬄy et al. Lyme disease,” American Journal of Medicine, vol. 114, no. 1, pp. 58–62, 2003. [3] G. Watt, “Leptospirosis,” in Hunter’s Tropical Medicine and Emerging Infectious Diseases, G. T. Strickland, Ed., pp. 452– 458, WB Saunders, Philadelphia, Pa, USA, 8th edition, 2000. [4] D. Raoult, H. Tissot-Dupont, C. Foucault, et al., “Q fever 1985–1998: clinical and epidemiologic features of 1,383 infections,” Medicine, vol. 79, no. 2, pp. 109–123, 2000. [5] J. M. Graham Jr., “Marshall J. Edwards: discoverer of maternal hyperthermia as a human teratogen,” Birth Defects Research Part A, vol. 73, no. 11, pp. 857–864, 2005. [6] Lexi-Comp OnlineTM, Hudson, Ohio: Lexi-Comp, Inc., December 2007. [7] N. C. Klein and B. A. Cunha, “Treatment of fever,” Infectious Disease Clinics of North America, vol. 10, no. 1, pp. 211–216, 1996. [8] B. Ameer and D. J. Greenblatt, “Acetaminophen,” Annals of Internal Medicine, vol. 87, no. 2, pp. 202–209, 1977. [9] http://www.fda.gov/cder/drug/infopage/penG doxy/doxypreg .htm, February 2008. [10] M. I. Buitrago, J. W. Ijdo, P. Rinaudo, et al., “Human granu- locytic ehrlichiosis during pregnancy treated successfully with rifampin,” Clinical Infectious Diseases, vol. 27, no. 1, pp. 213– 215, 1998. [11] A. Dhand, R. B. Nadelman, M. Aguero-Rosenfeld, F. A. Had- dad, D. P. Stokes, and H. W. Horowitz, “Human granulocytic anaplasmosis during pregnancy: case series and literature review,” Clinical Infectious Diseases, vol. 45, no. 5, pp. 589–593, 2007. 3